Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
about
Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.Novel Anti-fibrotic Therapies.Altered expression of PPAR‑γ and TRPC in neonatal rats with persistent pulmonary hypertension.Pulmonary hypertension: Molecular aspects of current therapeutic intervention and future direction.Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway
P2860
Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@en
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@nl
type
label
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@en
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@nl
prefLabel
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@en
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@nl
P2093
P2860
P1476
Pioglitazone alleviates cardia ...... lmonary arterial hypertension.
@en
P2093
Arnica Behringer
Ernst Wellnhofer
Eva Maria Berghausen
Evren Caglayan
Florian Blaschke
Henrik Ten Freyhaus
Kai Kappert
Manuela Trappiel
Margarete Odenthal
P2860
P2888
P304
P356
10.1007/S00210-015-1205-3
P577
2016-01-07T00:00:00Z
P6179
1028082163